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INTRODUCTION
Echolocating bats precisely regulate the acoustic properties of their
echolocation pulses to maximize the efficiency of their sonar
behavior (Chiu et al., 2009; Obrist, 1995; Schnitzler and Kalko,
2001). Like other bats, free-tailed bats (Tadarida brasiliensis)
constantly adjust the spectral and temporal parameters of their
pulses in response to auditory feedback and ever-changing
behavioral and environmental contexts (Gillam and McCracken,
2007; Gillam et al., 2007; Jarvis et al., 2010; Ratcliffe et al., 2004;
Schwartz et al., 2007; Simmons et al., 1978; Tressler and
Smotherman, 2009; Ulanovsky et al., 2004). In this regard the vocal
plasticity displayed by echolocating bats is uncommon among
mammals because it represents a cognitive rather than limbic
control of the vocal motor circuitry. Limited examples of
mammalian vocal plasticity have also been reported for primates
and cetaceans (Brumm et al., 2004; Cleveland and Snowdon, 1982;
Egnor and Hauser, 2006; Egnor et al., 2006; Egnor et al., 2007;
Ghazanfar et al., 2002; Insley and Southhall, 2005; Scheifele et
al., 2005) but the neural pathways guiding these behaviors have
yet to be explored.
Previous work has highlighted the role of the midbrain as a
substrate for audio-vocal integration in bats (Metzner and Schuller,
2007) but there is also evidence of a cortical network regulating bat
vocalizations (Gooler and O’Neill, 1986). Several lines of evidence
from studies of birdsong and human speech (Alm, 2004; Doupe and
Kuhl, 1999; Jarvis, 2004; Kuhl, 2003) have suggested that a suite
of forebrain nuclei known collectively as the basal ganglia (BG)
may play an important role in vocal plasticity among vertebrates.
In songbirds, the BG are essential for vocal learning but also provide
a substrate for sensory and contextual influences on vocalizing in
adults (Doupe et al., 2005; Kao et al., 2005; Woolley and Doupe,
2008). In humans, pathological dysfunctions of the BG contribute
to many of the most common human speech motor disorders, such
as stuttering (Alm, 2004) and dysarthrias (Goberman and Blomgren,
2003; Ho et al., 1999; Holmes et al., 2000; Louis et al., 2001;
Sanabria et al., 2001). It therefore appears that the BG have the
potential to contribute to some general aspects of mammalian vocal
plasticity but their precise functions remain unclear.
Consistent levels of striatal dopamine are necessary for the proper
functioning of motor control circuits (Alexander and Crutcher,
1990). In rats, unilateral lesions of the dopamine-producing cells of
the substantia nigra reduced mating call amplitudes and bandwidths
in a manner similar to the symptoms of Parkinsonian dysarthria in
humans (Ciucci et al., 2009; Ciucci et al., 2007). An alternative
method for knocking down dopamine production is through the use
the neurotoxin 1-methyl-4-phenylpyridine (MPTP). MPTP can
cross the blood–brain barrier and exerts its primary effects through
metabolic neurotoxicity of dopaminergic cells in the substantia nigra
pars compacta (SNc) (Bradbury et al., 1986). It has been widely
used to generate animal models of Parkinson’s disease (Smeyne
and Jackson-Lewis, 2005) but its effects on the mammalian vocal
motor pathways have not been described. MPTP has, so far, been
shown to be a potent catecholaminergic neurotoxin in primates, cats,
rats, mice and pigs but its efficacy and behavioral effects were found
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SUMMARY
The ability to control the bandwidth, amplitude and duration of echolocation pulses is a crucial aspect of echolocation
performance but few details are known about the neural mechanisms underlying the control of these voice parameters in any
mammal. The basal ganglia (BG) are a suite of forebrain nuclei centrally involved in sensory-motor control and are characterized
by their dependence on dopamine. We hypothesized that pharmacological manipulation of brain dopamine levels could reveal
how BG circuits might influence the acoustic structure of bat echolocation pulses. A single intraperitoneal injection of a low dose
(5mgkg–1) of the neurotoxin 1-methyl-4-phenylpyridine (MPTP), which selectively targets dopamine-producing cells of the
substantia nigra, produced a rapid degradation in pulse acoustic structure and eliminated the bat’s ability to make compensatory
changes in pulse amplitude in response to background noise, i.e. the Lombard response. However, high-performance liquid
chromatography (HPLC) measurements of striatal dopamine concentrations revealed that the main effect of MPTP was a fourfold
increase rather than the predicted decrease in striatal dopamine levels. After first using autoradiographic methods to confirm the
presence and location of D1- and D2-type dopamine receptors in the bat striatum, systemic injections of receptor subtype-specific
agonists showed that MPTP’s effects on pulse acoustics were mimicked by a D2-type dopamine receptor agonist (Quinpirole) but
not by a D1-type dopamine receptor agonist (SKF82958). The results suggest that BG circuits have the capacity to influence
echolocation pulse acoustics, particularly via D2-type dopamine receptor-mediated pathways, and may therefore represent an
important mechanism for vocal control in bats.
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to vary due to species-specific differences in metabolic processing
and neuronal uptake of MPTP and its metabolites (Riachi et al.,
1988).
We hypothesized that if MPTP was potent in bats, the resulting
reduction of striatal dopamine could reveal the extent to which
dopaminergic circuits contributed to the spontaneous production,
modulation and variability of echolocation pulses. We predicted that
reduced dopamine levels caused by MPTP administration would
lead to voice changes similar to those typical of Parkinsonian
dysarthria, namely decreased voice amplitude, duration and
bandwidth. To test whether the loss of striatal dopamine levels had
an effect on audio-vocal integration, we measured the bats’ ability
to make compensatory changes in voice loudness in response to
background noise (i.e. the Lombard response) before and after MPTP
treatment. Although our acoustic measurements supported our
hypotheses, subsequent measurements of striatal dopamine
concentrations revealed that MPTP increased rather than decreased
striatal dopamine. This led us to test whether administration of
dopamine receptor subtype-specific agonists could mimic the effects
of MPTP, which would allow an assignment of MPTP’s effects on
pulse acoustics to a particular dopamine receptor subtype. The results
of these experiments provide evidence that dopamine and the BG
may be involved in the control of bat echolocation pulse acoustics.
MATERIALS AND METHODS
Animal husbandry
A total of 37 [8 for MPTP, 9 for autoradiography, 15 for high-
performance liquid chromatography (HPLC), and 5 for in vivo
receptor pharmacology] male Mexican free-tailed bats, Tadarida
brasiliensis mexicana (I. Geoffroy 1824), were caught wild from a
year-round roost on the campus of Texas A&M University and
housed in the Texas A&M Department of Biology vivarium facility.
All animal care and handling procedures and experimental protocols
were approved by the Texas A&M animal care and use committee,
and all acoustic behavioral assays were performed exactly as
described previously (Jarvis et al., 2010; Schwartz et al., 2007;
Tressler and Smotherman, 2009). Animals receiving neurotoxin
injections were subsequently housed separately from the main
colony.
Acoustic methods
All experiments were performed in a sound-isolated room lined with
sound-absorbing 4 acoustic foam (model UNX-4; Sonex©, San Jose,
CA, USA), with the lights off. Recordings were made using a Brüel
& Kjaer Free-field S microphone (Type 4939; Nærum, Germany),
which has an inherent noise floor of approximately 30dB (re. 20P)
and a dynamic range of 35–164dB. Bats hung from the top of a
14cm (length)  14cm (width)  5cm (height) S wire mesh cage,
and their position and behavior were monitored remotely by infrared
video throughout the experiment. The distance and orientation of
the bat relative to the microphone were consistent because the bats
always preferred to hang from the top of the cage and face
downwards towards the microphone, which was centered 10cm from
the bottom of the cage. Slight changes in signal strength resulting
from head movements and beam projection paths can be averaged
out across conditions as long as a sufficient number of calls are
recorded, in this case at least 100 calls over approximately 1–2min.
Recorded intensity of acoustic stimuli was minimized by
surrounding the microphone with acoustic foam on all sides except
that facing the bat, which facilitated the digital extraction of
echolocation pulses from the background noise. We used the
methods of Penna and colleagues (Penna et al., 2005) to subtract
the contributions of stimulus amplitude on the measurements of
pulse amplitude by empirically measuring the average effect of the
noise stimulus on the measured amplitude of an artificially generated
echolocation pulse. Incoming signals were digitized with a National
Instruments DAQmx analog-to-digital converter (NI PCI-6251;
16bit, 200kHz, Austin, TX, USA), and viewed with an Avisoft
Recorder v.3.0 (Berlin, Germany). For acoustic analyses of the bats’
echolocation pulses, 100 echolocation pulses from each bat for each
dose, acoustic condition and time point were selected at random
from the recordings, and the pulse acoustic parameters bandwidth,
duration and intensity were extracted automatically using Avisoft
SASLab Pro v4.39 as described in Tressler and Smotherman
(Tressler and Smotherman, 2009). For temporal analyses, we used
256-point fast Fourier transforms (FFTs) with 93.75% overlap,
providing 976Hz spectral and 0.064ms temporal resolutions. For
spectral analysis 1024-point FFTs provided 244Hz spectral and
0.256ms temporal resolutions. The bats’ normal echolocation pulses
ranged in intensity from 80dB to 115dB sound pressure level (SPL).
Broadband noise stimuli were generated digitally with Tucker-
Davis Technology (TDT, Alachua, FL, USA) system III hardware
and the openEX software v5.4. The broadband noise was digitally
filtered to present a total signal bandwidth spanning a range of
15–100kHz, which covered the entire range of the two loudest
harmonic components of the echolocation pulses of Tadarida
brasiliensis mexicana. Stimuli were played through a Sony amplifier
(model #STR-DE598; Tokyo, Japan) driving a four-speaker array
composed of two Pioneer Ribbon Tweeters (ART-55D/301080;
Kawasaki, Japan) and two Pioneer Rifle Tweeters (ART-
59F/301081). Each speaker provided a flat (±3dB) output at 85dB
SPL across the principal frequency range of interest, roughly
15–60kHz.
The effect of broadband noise on the subject’s echolocation pulse
parameters (the Lombard response) was determined by subtracting
the mean value of each acoustic parameter in the presence of noise
from the mean value in the absence of noise for each parameter for
each subject. The effect of MPTP on the Lombard response was
determined by subtracting the mean Lombard response of individuals
treated with MPTP from the same individuals treated with saline
for each parameter for each subject.
Pharmacology
All drugs were obtained from Sigma Chemical Co. (St Louis, MO,
USA). Solid MPTP powder (catalog #M0896) was dissolved in
physiological saline at a concentration by which a 0.1ml
intraperitoneal injection resulted in final doses of 1mgkg–1, 5mgkg–1
or 10mgkg–1. For systemic manipulation of specific dopamine
receptor subtypes, we used the D1-type dopamine receptor agonist
SKF82958 (3-allyl-6-chloro-1-phenyl-1,2,4,5-tetrahydro-3-
benzazepine-7,8-diol; Sigma Chemical Co. #C130), the D1
antagonist SCH23390 (7-chloro-3-methyl-1-phenyl-1,2,4,5-
tetrahydro-3-benzazepin-8-ol; Sigma Chemical Co. #D054), the D2-
type dopamine receptor agonist Quinpirole [(4aR,8aR)-5-propyl-
4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinolone; Sigma
Chemical Co. #Q102] and the D2 antagonist Eticlopride (3-
chloro-5-ethyl-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-6-hydroxy-
2-methoxybenzamide; Sigma Chemical Co. #E101) dissolved in
physiological saline. Saline injections of equivalent volume were
used for controls.
The dosage and administration of MPTP was based on a review
of mouse models of Parkinson’s disease (Sedelis et al., 2001). In
mice a broad spectrum of dosages and administration schedules has
been reported to produce variable results depending in part on strain,
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age, sex and laboratory. Key factors in our choice of dose and
schedule were that: (1) we could not afford high mortality rates
because we were working with wild-caught animals; and (2) free-
tailed bats echolocate more freely when they are able to move and
actively explore their environment. We therefore devised an
administration schedule predicted to produce mild chronic effects
that accumulated over time. In mice, acute effects of MPTP
injections (30mgkg–1 and higher) have been reported to occur within
1h post-injection (Sedelis et al., 2001), and significant behavioral
deficits as well as the loss of dopaminergic neurons of the substantia
nigra became apparent after 24h and plateaued within four to seven
days (Jackson-Lewis et al., 1995). Some reports indicated mortality
rates as high as 60% after one day at doses as low as 30mgkg–1
(Sikiric et al., 1999), and our own preliminary trials with a single
20mgkg–1 dose in four bats resulted in 50% mortality and a severe
akinesia in the two surviving bats that lasted more than 48h and
precluded conducting any vocalization studies. We therefore carried
out experiments at three lower doses of 1mgkg–1, 5mgkg–1 and
10mgkg–1 administered by a single injection of 0.1ml of
physiological saline once a week for four weeks. For each MPTP
dose tested, three individual Mexican free-tailed bats were selected
at random and housed separately from the captive colony. One day
before MPTP administration (–1 day) each bat received a saline
injection, and 1h later their performance on the motor control assays
was assessed and their mean pulse acoustics and Lombard response
were quantified. After 24h the same individuals were then
administered with an MPTP injection. Post-MPTP administration,
acoustic recordings and motor control assessments were taken for
each bat 1h, 1 day and 7 days after MPTP injection (+1h, +1 day
and +7 days, respectively). This paradigm was repeated four times
for each dose. No effect of repeated administration was found and
the results of all trials were combined.
For each of the four dopamine receptor-specific drugs tested, five
individual bats received a 0.1ml intraperitoneal injection of either
one of the four drugs or saline and were immediately placed alone
in the recording cage and their spontaneous vocalizations
continuously recorded for up to 90min. Treatment order was
randomized and balanced across bats. Mean pulse acoustic
parameters were assessed by successive time bins within each trial
to characterize the time course of any potential drug effects. Visual
inspection of all records confirmed that only echolocation pulses
and not communication calls were included in the analyses.
HPLC
Whole brain tissue was harvested from 10 treated (5mgkg–1 MPTP;
5 at +1h and 5 at +1day) and 5 untreated (saline injected) bat brains
and flash frozen and stored at –80°C until dopamine analyses. Frozen
brains were blocked, mounted on a freezing microtome stage and
then sectioned at 150m through the striatum. Tissue sections were
placed on glass slides onto a freezing plate and the striatum was
micropunched under a surgical microscope using 0.75mm-diameter
metal core punches (Model 15072; Ted Pella, Redding, CA, USA).
Tissue concentrations of dopamine were determined using HPLC
(Kramer et al., 2007; Sved, 1989). Just prior to assay, the tissue
samples were weighed and sonicated in perchloric acid containing
dihydrobenzylamine (DHBA) (an internal standard, 100ngml–1;
ESA, Chelmsford, MA, USA). Each sample was centrifuged for
20min at 3200g at 4°C. The supernatant was passed through a low-
volume nylon 0.2micron filter (Model 8110; Fisher Scientific,
Houston, TX, USA) and the resulting supernatant was injected onto
a reversed phase C-18 column (Shiseido, 5cm, Model #A3RE01176;
ESA). The sample amines were eluted using a filtered and degassed
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mobile phase (MDTM-II; ESA) and then quantified by
electrochemistry (Coulochem II; ESA) using a microdialysis cell
(Model 5014B; ESA). Sample dopamine peak heights were
compared with external standard peak heights (Sigma Chemical Co.)
that were processed in a manner similar to that of the samples.
Sample values were expressed as amine concentrations (pg) per mg
wet mass of sample tissue.
Dopamine receptor autoradiography
To confirm the presence and location of D1- and D2-type dopamine
receptors in the Mexican free-tailed bat brain, we used slight
modifications of previously described protocols for dopamine
receptor autoradiography (Kim et al., 2000; Lidow et al., 1991). All
slides were pre-incubated in assay buffer (50mmoll–1 Tris HCl
buffer with 120mmoll–1 NaCl, 5mmoll–1 KCl, 2mmoll–1 CaCl2,
1mmoll–1 MgCl2, pH7.4) for 20min. To map the distribution of
D1-type dopamine receptors, the experimental slide sets from five
non-injected bats were first incubated for 1h at 23°C in assay buffer
with 1nmoll–1 N-methyl-3H-SCH23390 (Perkin-Elmer Corp., Foster
City, CA, USA), and 5moll–1 of the 5-HT2 serotonin receptor
antagonist ketanserin was added to prevent binding of the
radiolabeled ligand to serotonin receptors as described in Kim et
al. (Kim et al., 2000). Control slide sets were processed similarly
but with the addition of 5moll–1 of fluphenazine, a D1/D2 dopamine
receptor antagonist, which prevented binding of the radiolabeled
receptor antagonist to D1-type dopamine receptors and thereby
provided quantitative determination of non-specific binding. To map
D2-type dopamine receptors, the experimental slide sets from four
bats were incubated in assay buffer with 1nmoll–1 methoxy-3H-
raclopride (Perkin-Elmer Corp.) for 45min at 23°C. Control slide
sets were processed similarly but with the addition of 10moll–1
butaclamol, a D1/D2 dopamine receptor antagonist, to determine non-
specific binding. All slide sets were then transferred to ice-cold assay
buffer for two rinses of 20s each, followed by an ice-cold water
rinse of 10s. Finally, all slide sets were then dried and apposed to
BioMax Maximum Resolution autoradiographic film (Kodak) with
a calibrated 14C standard for 17–19weeks at –80°C.
All D1 and D2 films were developed and optical density
measurements from five sections on the experimental slide set were
measured and averaged for each brain area for each animal using
NIH Image J (Rasband, 1997). All sections were subsequently
stained with Cresyl Violet to aid in brain structure identification.
Areas exhibiting binding were also measured in control brains to
provide non-specific binding control data. The threshold for binding
in the autoradiography experiments was determined by adjusting
background level for each image according to the non-specific
binding levels obtained from the control slide sets. Any area with
binding higher than the non-specific binding levels was analyzed.
A standard curve was generated using the optical densities from the
calibrated standards. 3H-SCH23390 and 3H-raclopride binding
(nCimg–1 protein) from each brain region was calculated using the
values from the standard curve. Non-specific binding was subtracted
from total binding to determine specific binding for each brain
region.
Motor control assays
In order to determine if MPTP injections were having an effect on
gross motor control, motor control assays based on similar studies
in rodents were adapted for bats and performed at each experimental
session (Muralikrishnan and Mohanakumar, 1998; Sikiric et al.,
1999). Under normal circumstances an untreated Mexican free-tailed
bat placed at the center of the bottom of a cage will quickly move
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to the side of the chamber and climb to the highest point in the
cage. For these experiments, treated and untreated subjects were
placed individually into a 14145cm wire mesh arena, and the
time it took the subject to: (1) move all four limbs; and (2) climb
onto the wall of the arena were recorded. Additionally, the presence
and degree of tremor was scored by two observers on a 0–4 scale.
The bats’ ability to fly, avoid obstacles, land safely, and eat, drink
and groom were checked periodically throughout the study but we
did not force treated bats to fly.
Statistical analysis
The effect of MPTP on each bat was first tested using the raw
recorded values of each parameter. In order to more accurately
compare the effect between bats and gain an understanding of the
general effect of MPTP, two derived values were computed for each
parameter, i.e. the absolute mean and its relative difference from
that obtained following saline injections. The deviation from saline
was computed for pulses emitted in silence for each bat for each
pulse parameter by subtracting each bat’s mean parameter value
after saline injection from that bat’s mean parameter value after
MPTP injection for each time point. The effect of MPTP on the
Lombard response was calculated by subtracting the change caused
by noise after saline injection from the change caused by noise after
MPTP injection for each bat at each time point.
All statistical procedures were performed utilizing SAS-JMP
v.7.0.7 at the 0.05 level. Data were normally distributed with the
exception of the effect of MPTP on the mean Lombard response.
Overall effects of MPTP on echolocation pulse parameters were
analyzed by multivariate analysis of variance (MANOVA). If
significant, individual parameters were compared with analysis of
variance (ANOVA). Differences between individual treatments
within a parameter were tested with a Kruskal–Wallis one-way
ANOVA for the effects of MPTP on the Lombard response and a
Student’s t-test for all others, 0.05. Motor control assays were
analyzed by comparing pre- vs post-treatment scores using a non-
parametric c2 test. Results listed in the text are given as means 
± s.d.
RESULTS
Dose dependency of response to MPTP
The 1mgkg–1 dose of MPTP did not produce measurable signs of
extrapyramidal symptoms nor any significant change in any
echolocation call parameters or their response to broadband noise
(Fig.1; N3; MANOVA, P0.1056). However, the 10mgkg–1 dose
proved fatal within 2h of the injection in the first two bats tested
and was not repeated a third time. Within 30min after injections of
the 10mgkg–1 dose of MPTP, both treated bats exhibited profound
akinesia, a postural rigidity of the head and trunk, and brief periodic
episodes of violent wing tremors before suddenly expiring. The
5mgkg–1 dose of MPTP had a significant and obvious effect on all
echolocation pulse acoustic parameters (MANOVA, P<0.0001)
(illustrated in Fig.1) without causing symptoms or extrapyramidal
side effects similar to those caused by the 10mgkg–1 dose. All further
analysis pertains only to the 5mgkg–1 dose.
Effect of MPTP on behavioral motor assays
There was no significant effect of the 5mgkg–1 dose of MPTP on
either the time taken to move four limbs (P0.5165), time to cross
the arena (P0.4860) or on the presence of tremor (P0.4317). Only
one bat showed the presence of tremor on the day of and the day
after the first injection. At this dosage, no other visible signs of
MPTP-induced motor deficits were observed. Bats remained able
to self-feed and water, as well as climb and fly throughout the course
of the experiment.
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Fig.1. (A)Representative examples of how 1-methyl-4-phenylpyridine (MPTP) altered the acoustic structure of spontaneous echolocation pulses of one bat.
All bats received saline injections as pre-treatment controls one day before drug administration (–1day) and their echolocation pulses were recorded 1h
afterwards. +1hour reflects calls recorded 1h after receiving either a drug or saline injection on the day of treatment; +1day reflects calls recorded 24h after
injection; +7 days corresponds to calls recorded one week after treatment. Panels B–D provide the mean ± s.e.m. values for the echolocation pulse acoustic
parameters duration (B), amplitude (C) and bandwidth (D) for three bats receiving injections of either saline, 1mgkg–1 MPTP or 5mgkg–1 MPTP as their
primary treatment once a week for four weeks. Asterisks indicate a significant within-group difference from pre-treatment (–1day) measurements (P<0.05).
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Effect of MPTP on echolocation call parameters
All three bats displayed a similar pattern of change in response to
MPTP treatment for all acoustic parameters (Fig.2A). The effect
of MPTP on call parameters was significant (P<0.0001 for all) for
each bat. The complete list of acoustic parameter measurements for
each bat is presented in Table1. The mean deviation from saline is
an accurate representation of the individual response patterns (Fig.
2B) and will be the focus of further discussion.
Mean echolocation pulse amplitude in silence 1h after MPTP
injection was 104.8±3.2dB SPL, a significant decrease (P0.0049)
of 7.9±6.4dB SPL. One day after injection the mean amplitude was
105.5±5.3dB SPL, and the mean decrease of 8.4±5.1dB SPL was
still significantly less than pre-treatment recordings (P0.0005). By
the seventh day, the mean pulse amplitude was still significantly
less than pre-treatment levels by an average of 3.4±3.3dB SPL
(P0.0059) but had returned to near normal levels at 110.6±5.5dB
SPL (Fig.2B).
One hour after injection the mean duration of pulses uttered in
silence had decreased significantly by 43.4% to a value of 2.0±0.4ms
(P<0.0001). One day after injection the mean pulse duration was
2.6±0.4ms, still significantly less than the mean call duration
obtained with saline injections by 25.9% (P<0.0001). No significant
change from baseline was found 7 days after injection (P0.6836),
when pulse duration was only 5.5% less than saline levels at
3.3±0.7ms (Fig.2B).
MPTP significantly decreased pulse bandwidth 1h and 1 day after
injection (P<0.0001) but there was no longer a significant difference
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7 days after injection (P0.9984). Echolocation pulse bandwidth in
silence was 1.8±2.8kHz 1h after injection, 6.8±3.3kHz 1 day after
injection and 12.0±4.1kHz 7 days after injection, a decrease of
11.8±3.3kHz, 6.7±2.5kHz and 1.8±5.4kHz relative to saline
injections, respectively (Fig.2B).
Effect of MPTP on the Lombard response
MPTP had a significant effect on how bats altered their echolocation
pulses in response to broadband noise (MANOVA, P0.0072). The
baseline response to noise for saline injections was an increase in
amplitude of 9.7±2.2dB SPL, an increase in duration of 1.1±0.4ms
and a bandwidth increase of 4.7±3.4kHz.
The noise-induced change in pulse amplitude was significantly
affected by administration of MPTP (P0.0473). Following MPTP
injection, the mean echolocation pulse amplitude in broadband noise
was 108.3±6.3dB SPL 1h after injection, 111.8±7.8dB SPL 1 day
after injection and 119.8±5.3dB SPL 7 days after injection. The net
effect on the response to broadband noise was a decrease of
5.3±7.3dB SPL after 1h, a decrease of 0.3±6.6dB SPL after 1 day,
and an increase of 1.6±5.3dB SPL on day 7 (Fig.2C).
MPTP significantly affected the change in duration caused by
broadband noise (P0.0042). Mean echolocation duration in
broadband noise was significantly reduced to 2.4±1.0ms 1h after
injection (48.9% less than controls), 3.8±1.3ms 1 day after injection
(17.4% less) and increased to 5.0±0.7ms 7 days after injection (7.5%
greater) (Fig.2C), a significant change from the baseline response
(P0.0042).
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Fig.2. Relative effect of 1-methyl-4-phenylpyridine (MPTP) on echolocation pulse acoustics. (A)The effect of MPTP on the acoustic parameters of each of
the three bats receiving a 5mgkg–1 dose. Red bars correspond to pulses uttered in silence; blue in the presence of broadband noise. Asterisks (*) denote a
significant difference from measurements obtained following saline injections the day before. (B)Mean effect of MPTP on pulse parameters in silence. Each
bar denotes the mean of each bat’s deviation from saline for each parameter. (C)The effect of MPTP on the Lombard response. Each bar represents the
mean change in the response to noise of the three bats (B,C). Asterisks (*) denote a significant difference from zero change. Error bars are constructed with
± 2 s.e.m.
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The noise-evoked change in bandwidth was also significantly
affected by MPTP (P0.0228). One hour after injection the mean
pulse bandwidth in noise was reduced to 3.8±4.9kHz, then partially
recovered to 11.7±7.4kHz on day 1, and finally recovered to
18.1±3.7kHz on day 7. These values corresponded to a relative
change in the response to broadband noise of –2.2±4.4kHz after
1h, 2.4±6.1kHz after 1 day and 3.5±4.0kHz on day 7 (Fig.2C).
Effect of MPTP on striatal dopamine concentration
Bats receiving a 5mgkg–1 dose of MPTP and killed 1h later had
significantly (P0.001, 0.05) higher concentrations of striatal
dopamine (21.127±7.024pgmg–1, N5) relative to bats receiving
saline injections (5.760±1.236pgmg–1, N5). One day after MPTP
injections striatal dopamine was still elevated
(26.496±4.538pgmg–1, N5) and was not significantly different
from results obtained 1h after injection (P0.387). In the MPTP-
treated bats, we confirmed that echolocation pulses exhibited all the
acoustic changes described above at the time the animals were killed.
As the behavioral and acoustic measurements indicated that the
effects of MPTP only waned with time and did not change in nature,
we did not repeat this experiment at additional time points.
Dopamine receptor autoradiography
Both D1- and D2-type dopamine receptors were found co-localized
throughout the nucleus accumbens and the caudate putamen of
the Mexican free-tailed bat BG (Fig.3). Receptor distributions
appeared homogenously distributed throughout the striatum,
although binding was higher for both receptor subtypes in the
caudate putamen (D1: 0.00131±0.000193Cig–1, N5; D2:
0.00159±0.000249, N4) than in the nucleus accumbens (D1:
0.000984±0.000141Cig–1, N5; D2: 0.00118±0.000381, N4).
No other brain areas showed binding for either drug that was
significantly above background levels.
Effects of dopamine receptor subtype-specific drugs on pulse
acoustics
Administration of the D1-type dopamine receptor agonist SKF82958
at doses of 0.1mgkg–1, 1.0mgkg–1, 10mgkg–1 and 100mgkg–1
caused no significant change in the emission rate or acoustic
parameters of spontaneously emitted echolocation pulses. Testing
the D1-type receptor antagonist SCH23390 proved difficult because
doses as low as 100gkg–1 caused a rapid generalized akinesia,
which consequently eliminated all pulse emission. We ultimately
carried out experiments using the highest doses that produced only
mild akinesia, which were 1.0gkg–1 and 10gkg–1. However, at
these doses we saw no significant changes in any call acoustic
parameter. Pulse duration, a reliable indicator of any changes in
Mexican free-tailed bat pulse acoustics, did not vary significantly
across time (P0.9465) regardless of drug type (D1 agonist or
antagonist) or with dose (P0.1151). Likewise, neither SKF82958
nor SCH23390 caused mean pulse amplitudes to vary significantly
over time (P0.3702) regardless of treatment (P0.5439).
We tested the D2-type dopamine receptor agonist Quinpirole at
doses of 1mgkg–1, 10mgkg–1 and 50mgkg–1. After initial
recordings revealed the emergence of very short, narrow bandwidth
pulses similar to those seen following MPTP treatment (Fig.4A),
an analysis of co-variance (ANCOVA) with dose as a factor, bat
as a block and time after injection as a covariate confirmed a
significant effect of this drug on call durations (F2,305185,
P<0.0001). There was a significant interaction effect between dose
and time and the time effect varied with dose (F2,30542.1,
P<0.0001). The lowest dose caused a brief increase in call durations
between 20min and 40min after injection (Fig.4B), while the two
higher doses resulted in proportionally greater and more rapid
reductions in pulse duration (Fig.4B). Changes in pulse duration
were a reliable reflection of concurrent changes in bandwidth and
amplitude as illustrated in Fig.4A. This highest dose of Quinpirole
reduced but did not eliminate regular pulse emissions. Conversely,
the D2-type dopamine receptor antagonist Eticlopride had no
significant effects on the acoustic parameters of spontaneous pulse
emissions at any of the four doses tested, 0.1mgkg–1, 1.0mgkg–1,
10mgkg–1 and 100mgkg–1 (P0.1014). These doses were chosen
based on the literature and were predicted to achieve greater than
80% receptor occupancy in the striatum at the lowest dose.
DISCUSSION
The action of MPTP on the dopamine-producing cells of the SNc
in mammals is well established (Jakowec et al., 2004; Smeyne
and Jackson-Lewis, 2005). In the brain MPTP is metabolized to
1-methyl-4-phenylpyridinium (MPP+) by the enzyme monoamine
oxidase B. MPP+ selectively enters dopamine-producing cells via
their dopamine transporter (DAT). As the highest densities of DAT
are located in the midbrain substantia nigra and ventral tegmental
area, these neurons are preferentially impacted by MPTP injection.
Once inside the neuron MPP+ interferes with complex 1 of the
electron transport chain in mitochondria leading to the depletion
of ATP levels (Suzuki et al., 1990). Reduced cellular respiration
is not suspected of being the imminent cause of cell death
(Smeyne and Jackson-Lewis, 2005) but ATP depletion has been
linked to the abnormal release of dopamine from intracellular
stores into the striatum (Ofori and Schorderet, 1987; Rollema et
al., 1988). It appears likely that in our experiments MPTP did not
acutely kill catecholaminergic neurons within the same time
Table1. Data for three bats at four different time points before
(saline injected) and after (+1h, +1day and +7days) receiving a
5mgkg–1 MPTP injection
Amplitude Duration Bandwidth
Bat Time Treatment (dB SPL) (ms) (kHz)
1 Saline Silence 112.8±0.2 3.0±0.02 12.1±0.2
1 Saline Noise 119.9±0.3 3.7±0.03 18.7±0.3
1 +1h Silence 102.9±0.3 1.9±0.09 2.2±0.6
1 +1h Noise 108.5±0.8 2.9±0.15 6.4±0.7
1 +1 day Silence 103.5±0.5 2.3±0.10 5.0±0.6
1 +1 day Noise 107.8±0.7 3.8±0.15 13.6±0.8
1 +7 days Silence 108.3±0.2 2.9±0.02 9.5±0.1
1 +7 days Noise 114.4±0.3 3.7±0.03 16.0±0.2
2 Saline Silence 116.7±0.3 3.7±0.05 10.9±0.5
2 Saline Noise 126.6±0.4 5.2±0.07 17.7±0.9
2 +1h Silence 102.5±0.5 1.9±0.04 0.6±0.2
2 +1h Noise 103.4±0.3 1.9±0.09 1.2±0.6
2 +1 day Silence 112.1±0.2 2.6±0.03 8.9±0.2
2 +1 day Noise 118.3±0.3 4.4±0.06 14.6±0.4
2 +7 days Silence 114.7±0.2 3.9±0.03 14.8±0.2
2 +7 days Noise 121.3±0.3 5.6±0.05 20.3±0.4
3 Saline Silence 107.3±0.2 3.9±0.04 17.5±0.2
3 Saline Noise 118.2±0.3 5.1±0.05 18.2±0.4
3 +1h Silence 102.4±0.3 3.0±0.08 9.2±0.4
3 +1h Noise 107.6±0.4 3.9±0.11 12.7±0.5
3 +1 day Silence 103.2±0.2 3.1±0.03 11.4±0.2
3 +1 day Noise 108.5±0.2 5.0±0.04 17.3±0.2
3 +7 days Silence 105.6±0.1 3.5±0.02 14.6±0.1
3 +7 days Noise 111.9±0.2 5.0±0.03 17.1±0.2
Values are means ± 2 s.e.m. 
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frame that dramatic changes in pulse acoustics appeared. Instead,
MPTP administration appears to have caused an efflux of
dopamine into the striatum that led to significant reductions in
echolocation pulse duration, bandwidth and loudness. Since the
effects of MPTP on pulse acoustics gradually rescinded over the
ensuing week after injection, we assume that this was the time
course over which MPTP and its metabolites were cleared and
neurons recovered normal functioning. However, in mice an
80mgkg–1 dose of MPTP (four injections over eight hours) caused
a reduction in striatal dopamine that reached its nadir only after
three to seven days (Jakowec et al., 2004). We therefore cannot
rule out the possibility that the acute hyperdopaminergic conditions
were not subsequently replaced by cell death and
hypodopaminergic conditions at some point during the week after
injection. That question could be addressed with more HPLC
J. Tressler and others
measurements but it goes beyond the immediate goals of this
project.
In our initial experimental design we tested for the effects of
repeated low-dose administration of MPTP hoping to achieve a mild
chronic change in vocalizations. However, four weeks of repeated
injections produced no significant cumulative effects, although each
subsequent injection produced changes quantitatively similar to the
preceding injections. Had we shortened the time between injections
to once a day or every other day for four consecutive days, as has
been done in primates to achieve chronic effects (Albanese et al.,
1993; Jenner et al., 1984), we may have achieved hypodopaminergic
rather than hyperdopaminergic results. However, these experiments
were constrained by a limited number of animals and apparently a
fine threshold dose beyond which the drug appeared to be rapidly
lethal. Although the 1mgkg–1 dose had no measurable acoustic or
A B
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Fig.3. Autoradiographic localization of D1- and D2-type dopamine receptors in the Mexican free-tailed bat brain. (A)Representative autoradiograph showing
binding in the striatum in four adjacent brain sections (shown inset on the bottom left) incubated with 3H-SCH23390, a D1-type receptor antagonist.
(B)Binding in the striatum for four adjacent brain sections incubated with 3H-raclopride, a D2-type receptor antagonist. Panels i and ii are enlarged to the
right and overlaid with approximate boundaries of the caudate/putamen (CPu) and nucleus accumbens (Acb) based on Cresyl Violet-stained adjacent
sections (shown inset on the top left). LS, lateral septum; Acg, anterior cingulate cortex.
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Fig.4. (A)Representative example of how a 50mgkg–1 dose of Quinpirole acutely altered the acoustic structure of spontaneous echolocation pulses. (B)The
effect of three doses of Quinpirole on echolocation pulse duration in five bats. Pulse durations were binned and averaged over successive 5 min periods
beginning 20 min before drug injection (mean ± s.e.).
THE JOURNAL OF EXPERIMENTAL BIOLOGY
3245Dopamine effects on echolocation pulses
behavioral effects, the 5mgkg–1 dose dramatically altered
echolocation pulse acoustics without evidence of any other
significant motor deficits, and the 10mgkg–1 dose caused severe
deficits that were almost instantly lethal. The 5mgkg–1 dose may
have caused motor deficits that were not adequately reflected by
our simple motor assays. More sensitive assays possibly applied in
conjunction with different drug administration schedules would be
required to completely address the effects of MPTP on the bat’s
behavior and neurophysiology.
The hypothesis that MPTP interfered with echolocation pulse
production via a hyperdopaminergic mechanism is supported by the
observation that high doses of the D2-type dopamine receptor agonist
Quinpirole resulted in similarly distorted echolocation pulse
structures. Our observation that the lowest dose of Quinpirole caused
a slight increase in call durations while the two higher doses caused
decreases in call duration is consistent with previous reports of
Quinpirole evoking biphasic dose responses due to its actions at
pre-synaptic autoreceptors, which have a higher affinity for the drug
than post-synaptic D2 receptors (Lin and Walter, 1994; Plantje et
al., 1987). Activation of D2 autoreceptors has the net effect of
suppressing post-synaptic activity at D2 synapses, and if that was
the case here then the results imply that D2 receptors actively
influence the acoustic structure of spontaneously emitted
echolocation pulses. However, as the D2 antagonist Eticlopride had
no measureable effect on pulse acoustics, further studies are needed
to clarify this issue.
Dopamine’s effects on echolocation pulse acoustics
In humans, speech disorders can arise from either increases or
decreases in striatal dopamine concentrations, resulting in what are
known as hyperkinetic or hypokinetic dysarthrias, respectively
(Darley et al., 1969). In rats, Ciucci and colleagues found that striatal
dopamine depletions produced symptoms similar to hypokinetic
dysarthria, namely reduced call loudness and bandwidth (Ciucci et
al., 2009). Those symptoms can be accounted for by reduced
laryngeal and respiratory muscle tone. In our case, however,
although we observed similar changes in pulse acoustics, these
symptoms were more likely attributable to hypertonicity of the vocal
musculature. In humans, a condition known as hypertonic dysphonia
sometimes presents as a breathy and harsh whispering voice with
frequent interruptions resulting from an inability to articulate
correctly. These symptoms have been linked to abnormal increases
in BG dopamine levels (Duffy, 2005). Striatal dopamine levels
regulate the output of thalamocortical feedback pathways, which in
turn control activity in descending motor pathways (Herrero et al.,
2002), and elevated dopamine levels driving over activity of the
pyramidal speech motor pathways is thought to cause the
hypertonicity of the laryngeal musculature. In bats, it is not yet
known whether BG circuits are modulating the vocal motor pathway
via thalamocortical projections as in humans or through an
alternative BG output pathway that projects from the substantia nigra
pars reticulata to the midbrain components of the vocal motor
pathway (Grillner et al., 2005; Hikosaka, 2007; Sinha and Moss,
2007).
Changes in echolocation pulse loudness, duration and bandwidth
are likely to be interdependent consequences of biomechanical
constraints of the bat’s laryngeal apparatus. We have previously
shown in free-tailed bats that any changes in pulse duration and
bandwidth are positively correlated with amplitude (Tressler and
Smotherman, 2009). Any change in subglottic pressure is expected
to alter the frequency content of echolocation pulses due to the
mechanical properties of the larynx (Suthers and Fattu, 1973). The
primary effect of MPTP is hypothesized to be a reduction in voice
loudness, the biophysical consequences of which were concomitant
changes in call duration and bandwidth. Bats need high subglottic
pressures to generate high-frequency vocalizations. As MPTP
interfered with the bats’ ability to generate high subglottic pressures,
the high starting frequency of the downward frequency modulation
sweep should have been most sensitive to this change, and this is
what we observed (Figs2 and 4). It remains unclear however if the
effects of MPTP on call structure are attributable solely to changes
in respiratory drive or whether the drug also degraded the bats’
ability to articulate the laryngeal apparatus in a complex way. Ciucci
and colleagues speculated that striatal dopamine depletion may have
constrained fine sensorimotor processes needed for the articulation
of more complex broadband vocalizations in rats (Ciucci et al.,
2009). It may also be the case that hypertonic laryngeal conditions
similarly interfere with articulatory mechanisms in both bats and
humans.
Dopamine agonists can suppress vocalization emission rates in
rodents (Cuomo et al., 1987; Dastur et al., 1999), and D2 agonists
can generally suppress motor activity in rats (Tidey and Miczek,
1992). Cuomo and colleagues reported that early chronic exposure
to the D1 antagonist SCH23390 increased isolation call durations
and loudness and decreased frequency parameters, while the D2
antagonist sulpiride reduced isolation call amplitudes (Cuomo et
al., 1987). However, these results were attributed to changes in
motivational and reward circuitry and not necessarily to changes in
vocal motor control. Systemic administration of dopaminergic
agonists may alter vocalizing for several reasons, including changes
in motivation, activity levels or physiological responses, such as a
change in body temperature (Dastur et al., 1999). The advantage of
testing the effects of these drugs on bat echolocation pulses is that
while motivation may be important for overall emission rates, the
acoustic structure and precise timing of echolocation pulse emissions
is dictated by cognitive rather than limbic factors. Bats must use
echolocation pulses to navigate similarly regardless of emotive or
motivational context. For this reason, the observed changes in
echolocation pulse acoustics caused by hyperdopaminergic
conditions can be reliably assigned to changes in the properties of
the motor control circuitry rather than the perceptual or motivating
conditions driving vocalizing. Given that the behavioral assays
showed no major motor defects and that the bats were capable of
normal locomotion (including flight), the change in dopamine seems
to have had a larger impact on the bats’ ability to regulate the vocal
control musculature than the locomotor muscles, although it should
be noted that muscle force amplitude was not directly measured for
any motor system during these experiments. It is possible that very
small changes in respiratory or laryngeal muscle force may have a
more pronounced effect on vocalizing than similar changes in other
motor systems due to the ballistic nature of animal vocalizations.
MPTP effect on the Lombard response
One potential advantage of using bat echolocation performance for
this study was that we could exploit their compensatory changes in
pulse loudness in the presence of background noise as a means of
testing the role of dopamine in audio-vocal integration. In stationary
bats MPTP treatment appeared to strongly suppress the Lombard
response, although in two of three bats the noise stimuli continued
to evoke a small increase in pulse loudness. This evidence supports
the hypothesis that the BG may be making an important contribution
to the integration of auditory sensory cues into the volitional vocal
motor commands but also leaves open the possibility that other
mechanisms also contribute to the behavior. For example, it was
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previously shown that decerebrate cats retained some evidence of
a Lombard response (Nonaka et al., 1997), indicating that the
Lombard response may depend upon brainstem reflexes. In an intact
animal such reflexes may be regulated by BG outputs (Hikosaka,
2007). In the MPTP-treated bats, the Lombard response appeared
to recover in conjunction with the return of normal pulse structures,
raising some questions about whether in fact this was a reliable test
of the sensorimotor control circuitry. If the bats could not produce
normal echolocation pulses then it is difficult to know whether or
not the sensorimotor circuitry might have been performing normally
in the background. Audio-vocal feedback might have been correctly
delivered to but not implemented by the vocal motor apparatus.
Seven days after receiving an MPTP injection the noise-induced
changes in one acoustic parameter, pulse bandwidth, had rebounded
to a value significantly greater than the pre-treatment response to
noise, indicating that the bats exhibited a relatively stronger Lombard
response following recovery from the MPTP treatment. The mean
values for all three acoustic parameters appeared to return to values
slightly exceeding their original measurements. Interestingly, the
Lombard response seems to have recovered within one day after
MPTP injections while baseline pulse acoustics and the striatal
dopamine levels remained significantly elevated. This may reflect
an adaptive response to the suppressive effects of a
hyperdopaminergic condition, which will have to be addressed with
future work.
Localization of dopamine receptor subtypes
In this study, both D1 and D2 receptors were found primarily in the
caudate putamen and nucleus accumbens, showing a similar
distribution to those reported in other mammals. This indicates that
the effects of MPTP and Quinpirole are probably the result of
changes in striatal dopamine concentrations. In the rat, dopamine
receptors were found throughout the forebrain with autoradiography,
with the highest levels in the caudate putamen, nucleus accumbens
and olfactory tubercle (Boyson et al., 1986). Lower levels were
detected in areas of the cortex, amygdala, globus pallidus and
hippocampus, among others. There could be D1 and D2 receptors
in other areas of the Mexican free-tailed bat brain that were too low
in density to find with this technique; Fig.3 offers some indication
that D1 receptors may be broadly distributed throughout the cortex
at low densities. D1 receptor density was at least threefold higher
than D2 receptor density in all areas in the rat, while in the bat we
found approximately the same densities of the two receptor types
within the striatum. Humans, monkeys and cats have a similar
distribution and D1/D2 ratio to that seen in the rat (Camps et al.,
1989; Lidow et al., 1991; Richfield et al., 1987). It was suggested
that the higher ratio was due to the fact that an antagonist was used
for the D1 receptor type while an agonist was used for the D2 receptor
type because dopamine antagonists bind both high and low affinity
states of receptors while agonists only label the high affinity states
(Camps et al., 1990). This study used antagonists for both receptor
types, which may explain the nearly 1:1 ratio reported here. Also,
another analysis in humans using SCH23390 and raclopride reported
a ratio similar to the bat, further supporting the suggestion that the
radioligands used might account for discrepancies in the
measurements of receptor densities (Hall et al., 1988).
CONCLUSIONS
The BG are suspected of playing an important role in the regulation
of human speech production (Alm, 2004; Duffy, 2005) but their
precise functions in normal speech or any other mammalian
vocalization remain poorly understood. In spontaneously
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echolocating bats, increasing striatal dopamine concentrations or
selectively activating D2-type dopaminergic synapses dramatically
but reversibly altered the acoustic structure and loudness of
echolocation pulses. Importantly, results presented here qualitatively
mimicked some of the symptoms of hyperkinetic dysarthria observed
in humans, which may have important implications for
understanding how pathological disruption of the BG circuitry
impacts the speech motor control circuitry. These changes indicate
that the dopaminergic tone in the BG is an important factor for the
correct production of bat echolocation pulses. Further work is needed
to define the precise contributions of the BG in the broader context
of both mammalian vocalizations and bat echolocation behavior.
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